Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure and Classes01:25

Antibody Structure and Classes

4.2K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
4.2K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

149
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
149
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

928
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
928
Viral Structure00:56

Viral Structure

63.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
63.9K
Antibody Structure01:10

Antibody Structure

61.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current HIV Research Thematic Issue on "HIV Vaccine Development".

Current HIV research·2026
Same author

Learned young: HIV-1 germline-targeting vaccination in infants.

Current opinion in HIV and AIDS·2026
Same author

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Nature·2026
Same author

Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144.

bioRxiv : the preprint server for biology·2026
Same author

The SLC15A4-LAMTOR1 interaction licenses endolysosomal TLR-mediated mTOR signaling and inflammatory cytokine production.

bioRxiv : the preprint server for biology·2026
Same author

Structure and functional diversity of antibodies targeting the <i>P. falciparum</i> circumsporozoite protein C-terminal domain.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Sep 14, 2025

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.4K

The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.

P J Klasse1, Rogier W Sanders2,3, Andrew B Ward4

  • 1Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA. pek2003@med.cornell.edu.

Nature Reviews. Microbiology
|July 23, 2025
PubMed
Summary

Developing an effective AIDS vaccine requires inducing broadly neutralizing antibodies against HIV-1. Researchers are exploring structure-guided immunogen design to elicit these potent antibodies for prevention and therapy.

More Related Videos

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
10:50

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding

Published on: September 15, 2010

9.7K
Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
11:45

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Published on: March 8, 2012

12.3K

Related Experiment Videos

Last Updated: Sep 14, 2025

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.4K
Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
10:50

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding

Published on: September 15, 2010

9.7K
Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
11:45

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Published on: March 8, 2012

12.3K

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • The AIDS pandemic necessitates an effective vaccine to prevent new human immunodeficiency virus type 1 (HIV-1) infections.
  • Broadly neutralizing antibodies (bNAbs) are crucial for blocking HIV-1 entry by targeting the viral envelope glycoprotein.
  • HIV-1's envelope glycoprotein employs mechanisms like sequence variation and glycan shielding to evade antibody responses.

Purpose of the Study:

  • To review the landscape of broadly neutralizing human antibodies against HIV-1.
  • To discuss the targets, characteristics, and limitations of current bNAb isolation and elicitation strategies.
  • To highlight advancements in structure-guided immunogen design for vaccine development.

Main Methods:

  • Review of scientific literature on HIV-1 broadly neutralizing antibodies.
  • Analysis of antibody epitope clusters on the HIV-1 envelope glycoprotein.
  • Examination of structure-guided immunogen design strategies.

Main Results:

  • Numerous bNAbs have been isolated, targeting diverse epitope clusters covering the HIV-1 envelope glycoprotein surface.
  • These bNAbs exhibit varied potency, mechanisms of action, and binding kinetics.
  • Current immunization strategies have not yet elicited bNAb responses.

Conclusions:

  • Despite challenges posed by HIV-1's defenses, bNAbs offer therapeutic and preventive potential.
  • Structure-guided immunogen design shows promise for eliciting bNAbs by engaging germline antibody precursors.
  • Further research in immunogen design is critical for advancing HIV-1 vaccine development.